Skip to Main Content
LICENSES AND NOTICES

License for Use of "Physicians' Current Procedural Terminology", (CPT) Fourth Edition

End User/Point and Click Agreement: CPT codes, descriptions and other data only are copyright 2009 American Medical Association (AMA). All Rights Reserved (or such other date of publication of CPT). CPT is a trademark of the AMA.

You, your employees and agents are authorized to use CPT only as contained in the following authorized materials including but not limited to CGS fee schedules, general communications, Medicare Bulletin, and related materials internally within your organization within the United States for the sole use by yourself, employees, and agents. Use is limited to use in Medicare, Medicaid, or other programs administered by the Centers for Medicare & Medicaid Services (CMS). You agree to take all necessary steps to insure that your employees and agents abide by the terms of this agreement.

Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CPT for resale and/or license, transferring copies of CPT to any party not bound by this agreement, creating any modified or derivative work of CPT, or making any commercial use of CPT. License to use CPT for any use not authorized here in must be obtained through the AMA, CPT Intellectual Property Services, 515 N. State Street, Chicago, IL 60610. Applications are available at the AMA websiteExternal Website.

This product includes CPT which is commercial technical data and/or computer data bases and/or commercial computer software and/or commercial computer software documentation, as applicable which were developed exclusively at private expense by the American Medical Association, 515 North State Street, Chicago, Illinois, 60610. U.S. Government rights to use, modify, reproduce, release, perform, display, or disclose these technical data and/or computer data bases and/or computer software and/or computer software documentation are subject to the limited rights restrictions of DFARS 252.227-7015(b)(2)(June 1995) and/or subject to the restrictions of DFARS 227.7202-1(a)(June 1995) and DFARS 227.7202-3(a)June 1995), as applicable for U.S. Department of Defense procurements and the limited rights restrictions of FAR 52.227-14 (June 1987) and/or subject to the restricted rights provisions of FAR 52.227-14 (June 1987) and FAR 52.227-19 (June 1987), as applicable, and any applicable agency FAR Supplements, for non-Department Federal procurements.

AMA Disclaimer of Warranties and Liabilities.

CPT is provided "as is" without warranty of any kind, either expressed or implied, including but not limited to, the implied warranties of merchantability and fitness for a particular purpose. AMA warrants that due to the nature of CPT, it does not manipulate or process dates, therefore there is no Year 2000 issue with CPT. AMA disclaims responsibility for any errors in CPT that may arise as a result of CPT being used in conjunction with any software and/or hardware system that is not Year 2000 compliant. No fee schedules, basic unit, relative values or related listings are included in CPT. The AMA does not directly or indirectly practice medicine or dispense medical services. The responsibility for the content of this file/product is with CGS or the CMS and no endorsement by the AMA is intended or implied. The AMA disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this file/product. This Agreement will terminate upon notice if you violate its terms. The AMA is a third party beneficiary to this Agreement.

CMS Disclaimer

The scope of this license is determined by the AMA, the copyright holder. Any questions pertaining to the license or use of the CPT must be addressed to the AMA. End Users do not act for or on behalf of the CMS. CMS DISCLAIMS RESPONSIBILITY FOR ANY LIABILITY ATTRIBUTABLE TO END USER USE OF THE CPT. CMS WILL NOT BE LIABLE FOR ANY CLAIMS ATTRIBUTABLE TO ANY ERRORS, OMISSIONS, OR OTHER INACCURACIES IN THE INFORMATION OR MATERIAL CONTAINED ON THIS PAGE. In no event shall CMS be liable for direct, indirect, special, incidental, or consequential damages arising out of the use of such information or material.

This license will terminate upon notice to you if you violate the terms of this license. The AMA is a third party beneficiary to this license.

POINT AND CLICK LICENSE FOR USE OF "CURRENT DENTAL TERMINOLOGY", ("CDT")

End User License Agreement

These materials contain Current Dental Terminology, Fourth Edition (CDT), copyright © 2002, 2004 American Dental Association (ADA). All rights reserved. CDT is a trademark of the ADA.

THE LICENSE GRANTED HEREIN IS EXPRESSLY CONDITIONED UPON YOUR ACCEPTANCE OF ALL TERMS AND CONDITIONS CONTAINED IN THIS AGREEMENT. BY CLICKING BELOW ON THE BUTTON LABELED "I ACCEPT", YOU HEREBY ACKNOWLEDGE THAT YOU HAVE READ, UNDERSTOOD AND AGREED TO ALL TERMS AND CONDITIONS SET FORTH IN THIS AGREEMENT.

IF YOU DO NOT AGREE WITH ALL TERMS AND CONDITIONS SET FORTH HEREIN, CLICK BELOW ON THE BUTTON LABELED "I DO NOT ACCEPT" AND EXIT FROM THIS COMPUTER SCREEN.

IF YOU ARE ACTING ON BEHALF OF AN ORGANIZATION, YOU REPRESENT THAT YOU ARE AUTHORIZED TO ACT ON BEHALF OF SUCH ORGANIZATION AND THAT YOUR ACCEPTANCE OF THE TERMS OF THIS AGREEMENT CREATES A LEGALLY ENFORCEABLE OBLIGATION OF THE ORGANIZATION. AS USED HEREIN, "YOU" AND "YOUR" REFER TO YOU AND ANY ORGANIZATION ON BEHALF OF WHICH YOU ARE ACTING.

  1. Subject to the terms and conditions contained in this Agreement, you, your employees, and agents are authorized to use CDT-4 only as contained in the following authorized materials and solely for internal use by yourself, employees and agents within your organization within the United States and its territories. Use of CDT-4 is limited to use in programs administered by Centers for Medicare & Medicaid Services (CMS). You agree to take all necessary steps to ensure that your employees and agents abide by the terms of this agreement. You acknowledge that the ADA holds all copyright, trademark and other rights in CDT-4. You shall not remove, alter, or obscure any ADA copyright notices or other proprietary rights notices included in the materials.
  2. Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CDT-4 for resale and/or license, transferring copies of CDT-4 to any party not bound by this agreement, creating any modified or derivative work of CDT-4, or making any commercial use of CDT-4. License to use CDT-4 for any use not authorized herein must be obtained through the American Dental Association, 211 East Chicago Avenue, Chicago, IL 60611. Applications are available at the American Dental Association websiteExternal Website.
  3. Applicable Federal Acquisition Regulation Clauses (FARS)\Department of Defense Federal Acquisition Regulation Supplement (DFARS) Restrictions Apply to Government use. Please click here to see all U.S. Government Rights Provisions.
  4. ADA DISCLAIMER OF WARRANTIES AND LIABILITIES. CDT-4 is provided "as is" without warranty of any kind, either expressed or implied, including but not limited to, the implied warranties of merchantability and fitness for a particular purpose. No fee schedules, basic unit, relative values or related listings are included in CDT-4. The ADA does not directly or indirectly practice medicine or dispense dental services. The sole responsibility for the software, including any CDT-4 and other content contained therein, is with (insert name of applicable entity) or the CMS; and no endorsement by the ADA is intended or implied. The ADA expressly disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this file/product. This Agreement will terminate upon notice to you if you violate the terms of this Agreement. The ADA is a third-party beneficiary to this Agreement.
  5. CMS DISCLAIMER. The scope of this license is determined by the ADA, the copyright holder. Any questions pertaining to the license or use of the CDT-4 should be addressed to the ADA. End users do not act for or on behalf of the CMS. CMS DISCLAIMS RESPONSIBILITY FOR ANY LIABILITY ATTRIBUTABLE TO END USER USE OF THE CDT-4. CMS WILL NOT BE LIABLE FOR ANY CLAIMS ATTRIBUTABLE TO ANY ERRORS, OMISSIONS, OR OTHER INACCURACIES IN THE INFORMATION OR MATERIAL COVERED BY THIS LICENSE. In no event shall CMS be liable for direct, indirect, special, incidental, or consequential damages arising out of the use of such information or material.

The license granted herein is expressly conditioned upon your acceptance of all terms and conditions contained in this agreement. If the foregoing terms and conditions are acceptable to you, please indicate your agreement by clicking below on the button labeled "I ACCEPT". If you do not agree to the terms and conditions, you may not access or use the software. Instead, you must click below on the button labeled "I DO NOT ACCEPT" and exit from this computer screen.


Impact

Print | Bookmark | Email | Font Size: + |

April 12, 2024

April 2024 HCPCS Updates – New, Revised, and Discontinued HCPCS Codes and Modifiers – Revised

The following information is based on the April 2024 Healthcare Common Procedure Coding System (HCPCS) file. These updates were effective April 1, 2024.

Note: That the appearance of a HCPCS code does not mean it is covered by the DME MAC.

This list shows HCPCS codes that will be effective April 1, 2024.

HCPCS DESCRIPTION
A4271 Integrated lancing and blood sample testing cartridges for home blood glucose monitor, per month
A4593 Neuromodulation stimulator system, adjunct to rehabilitation therapy regime
A4594 Neuromodulation stimulator system, adjunct to rehabilitation therapy regime, mouthpiece each
E0152 Walker, battery powered, wheeled, folding, adjustable or fixed height
E0468 Home ventilator, dual-function respiratory device, also performs additional function of cough stimulation, includes all accessories, components and supplies for all functions
E0736 Transcutaneous tibial nerve stimulator
E0738 Upper extremity rehabilitation system providing active assistance to facilitate muscle re-education, include microprocessor, all components and accessories
E0739 Rehab system with interactive interface providing active assistance in rehabilitation therapy, includes all components and accessories, motors, microprocessors, sensors
E2104 Home blood glucose monitor for use with integrated lancing/blood sample testing cartridge
E2298 Complex rehabilitative power wheelchair accessory, power seat elevation system, any type
J0177 Injection, aflibercept hd, 1 mg
J0209 Injection, sodium thiosulfate (hope), 100 mg
J0577 Injection, buprenorphine extended-release (brixadi), less than or equal to 7 days of therapy
J0578 Injection, buprenorphine extended-release (brixadi), greater than 7 days and up to 28 days of therapy
J0589 Injection, daxibotulinumtoxina-lanm, 1 unit
J0650 Injection, levothyroxine sodium, not otherwise specified, 10 mcg
J0651 Injection, levothyroxine sodium (fresenius kabi) not therapeutically equivalent to j0650, 10 mcg
J0652 Injection, levothyroxine sodium (hikma) not therapeutically equivalent to j0650, 10 mcg
J1010 Injection, methylprednisolone acetate, 1 mg
J1202 Miglustat, oral, 65 mg
J1203 Injection, cipaglucosidase alfa-atga, 5 mg
J1323 Injection, elranatamab-bcmm, 1 mg
J1434 Injection, fosaprepitant (focinvez), 1 mg
J2277 Injection, motixafortide, 0.25 mg
J2782 Injection, avacincaptad pegol, 0.1 mg
J2801 Injection, risperidone (rykindo), 0.5 mg
J2919 Injection, methylprednisolone sodium succinate, 5 mg
J3055 Injection, talquetamab-tgvs, 0.25 mg
J3424 Injection, hydroxocobalamin, intravenous, 25 mg
J7165 Injection, prothrombin complex concentrate, human-lans, per i.u. of factor ix activity
J7354 Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg)
J9073 Injection, cyclophosphamide (ingenus), 5 mg
J9074 Injection, cyclophosphamide (sandoz), 5 mg
J9075 Injection, cyclophosphamide, not otherwise specified, 5 mg
J9248 Injection, melphalan (hepzato) 1 mg
J9249 Injection, melphalan (apotex), 1 mg
J9255 Injection, methotrexate (Accord), not therapeutically equivalent to J9260, 50 mg
J9376 Injection, pozelimab-bbfg, 1 mg
K1037 Docking station for use with oral device/appliance used to reduce upper airway collapsibility
L1320 Thoracic, pectus carinatum orthosis, sternal compression, rigid circumferential frame with anterior and posterior rigid pads, custom fabricated
L5783 Addition to lower extremity, user adjustable, mechanical, residual limb volume management system
L5841 Addition, endoskeletal knee-shin system, polycentric, pneumatic swing, and stance phase control
Q5133 Injection, tocilizumab-bavi (tofidence), biosimilar, 1 mg
Q5134 Injection, natalizumab-sztn (tyruko), biosimilar, 1 mg

The following HCPCS codes have description/verbiage changes that will be effective April 1, 2024.

HCPCS DESCRIPTION
E2001 Suction pump, home model, portable or stationary, electric, any type, for use with external urine and/or fecal management system
J0208 Injection, sodium thiosulfate (pedmark), 100 mg
J0612 Injection, calcium gluconate, not otherwise specified, 10 mg
J0613 Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg
J3380 Injection, vedolizumab, intravenous, 1 mg
J3425 Injection, hydroxocobalamin, intramuscular, 10 mcg
J7516 Injection, cyclosporine, 250 mg
J9029 Intravesical instillation, nadofaragene firadenovec-vncg, per therapeutic dose
J9260 Injection, methotrexate sodium, 50 mg
J9071 Injection, cyclophosphamide (auromedics), 5 mg
J9072 Injection, cyclophosphamide (dr. reddy's), 5 mg

The following listing contains discontinued HCPCS codes, along with the cross-walked HCPCS codes (if applicable). Please note, not all discontinued HCPCS codes will have a cross-walked HCPCS code. 

HCPCS DISCONTINUE DATE CROSSWALK HCPCS CODE
E2300 03/31/2024  
J0576 03/31/2024  
J1020 03/31/2024  
J1030 03/31/2024  
J1040 03/31/2024  
J1840 03/31/2024  
J1850 03/31/2024  
J2920 03/31/2024  
J2930 03/31/2024  
J9070 03/31/2024  
J9250 03/31/2024  

Publication History

March 8, 2024 Originally Published
April 12, 2024 Added HCPCS codes J0577, J0578, J1010, J1202, J2919, J7354, J9073, J9074, J9075, J9248, J9249, J9255

spacer

26 Century Blvd Ste ST610, Nashville, TN 37214-3685 © 2025 CGS Administrators, LLC. All Rights Reserved